This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated September 2026 quarter results approved; standalone revenue up 27%, profit up 35%
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than Nifty Smallcap 250 and 3.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 September 2026, the Board approved unaudited results; consolidated amounts are not stated here. Standalone September-quarter revenue was Rs 242.00 crore versus Rs 189.96 crore a year earlier, and profit after tax was Rs 57.92 crore versus Rs 42.98 crore. Standalone half-year operating cash flow was Rs 173.29 crore. Prior periods were restated after Medinova transactions; the review was unmodified.
Standalone growth may support the stock, but investors should check the consolidated figures and restated comparisons.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹255.4 Cr | ₹201.6 Cr | +26.7% |
| Operating profit | ₹74.47 Cr | ₹51.73 Cr | +43.9% |
| Profit after tax | ₹59.47 Cr | ₹43.28 Cr | +37.4% |
| EBITDA margin | 44.1% | 40.6% | +3.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.